Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

Bon Health vs Trimi

By GLP-1 ScorecardUpdated

Bon HealthFactor scores not reassessed.
Site position #128

Lower score

Trimi
Site position #8

Higher score

Score comparison

Trimi has the higher recorded score — 86.4/100 to 69.7/100.

Trimi grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. Trimi combines compounded injections and care in monthly or prepaid plans; the annual discount is substantial, but prescription-issued refund limits deserve equal attention.

Before you choose

Before comparing the headline prices, the Bon Health review and the Trimi review set out the plan length, renewal date and extra fees behind each semaglutide figure in the table below, and the semaglutide cost page compares published rates across the field. A lower starting price can still mean a larger bill once a longer commitment or a separate membership is added.

If neither one fits, Andrew Meds vs Bon Health and boostAGErx vs Trimi compare each of them with another graded program, and the list of alternatives to Bon Health ranks the programs closest to Bon Health on price, features and score. Those pages, like every entry in the review directory, use the same six graded factors, so the scores carry across.

Of the sellers that pay us a commission, the Peter MD review covers one graded close to these two, at 78.1/100. That relationship never changes a grade, and the review lists what we could not verify.

We may earn a commission through these links, at no extra cost to you. Commercial relationships affect placement, but never the WeighScore or our editorial findings. See our disclosure.

Factor by factor

These are recorded editorial marks, not a measure of clinical outcomes. Current prices and terms may differ from those used in the marks. See the methodology.

Cost valueTrimi +18
75
93
Dose & formulationTrimi +20
64
84
Clinical oversightBon Health +3
85
82
Labs & monitoringTrimi +28
55
83
FulfillmentTrimi +18
72
90
Contract termsTrimi +31
53
84
Bon Health · top barTrimi · bottom bar

The numbers

Swipe or scroll to compare both providers.

MetricBon HealthTrimi
WeighScore69.7/10086.4/100
GradeCB
Site position#128#8
Semaglutide$220/mo advertised on monthly billing; $1,140 billed yearly at the $95/mo equivalent$175/mo month-to-month · $99/mo only on a 12-month prepay ($1,188 in one charge)
Tirzepatide$285/mo advertised on monthly billing; $1,620 billed yearly at the $135/mo equivalent$235/mo month-to-month · $125/mo only on a 12-month prepay ($1,500 in one charge)
CoverageConfirm eligibility for the selected treatmentAll 50 states
Brand-name accessNot confirmedNot confirmed
Oral / sublingualNot confirmedNot confirmed
Bon Health

Site position #128 · C

Factor scores not reassessed.

Strengths

  • Product pages show separate monthly, quarterly, six-month and annual totals
  • Product pages advertise no membership fee
  • The site identifies its merchant of record

What to consider

  • The lowest monthly equivalents require annual billing
  • The public site terms do not settle the refund on an unused prepaid balance
  • Confirm the assigned pharmacy and selected invoice before paying
Trimi

Site position #8 · B

Strengths

  • Separate semaglutide and tirzepatide plans include prescribed medication and care
  • Monthly, quarterly, six-month and annual charges published
  • BelieveRx pharmacy and Arora Health care network publicly named; individual assignment and licenses still need confirmation
  • Supplies and shipping included under the published offer

What to consider

  • Compounded injections only; no current branded or oral route
  • Monthly and quarterly plans renew automatically; six-month and annual continuation needs a new confirmed purchase
  • Ordinary orders become nonrefundable once the prescription is issued, even before shipping
  • A named pharmacy partner does not independently verify the pharmacy assigned to your order

Featured provider

CoreAge Rx

CoreAge Rx scores 89.5/100 (B+). Advertises pricing across doses with no membership fee, but starting-price displays and FAQ payment/refund promises need to be reconciled with the selected plan and refund policy.

Commercial relationships affect this placement. The score comparison above is separate.

Prices and terms can change; confirm them with the provider. Our factor scores may reflect earlier assessments; see our methodology. Not medical advice; see our disclosure.

← Back to the scorecard